Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011

Global Markets Direct, July 2011, Pages: 55

Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - Q2 2011” provides data on the Lexicon Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Lexicon Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Lexicon Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Lexicon Pharmaceuticals, Inc. - Brief Lexicon Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lexicon Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lexicon Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lexicon Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Lexicon Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lexicon Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lexicon Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lexicon Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lexicon Pharmaceuticals, Inc. and identify potential opportunities in those areas.

List of Tables
List of Figures
Lexicon Pharmaceuticals, Inc. Snapshot
Lexicon Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Lexicon Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Lexicon Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Lexicon Pharmaceuticals, Inc. – Pipeline Products Glance
Lexicon Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Lexicon Pharmaceuticals, Inc. – Drug Profiles
LX1031
Product Description
Mechanism of Action
R&D Progress
LX1032
Product Description
Mechanism of Action
R&D Progress
LX2931
Product Description
Mechanism of Action
R&D Progress
LX1033
Product Description
Mechanism of Action
R&D Progress
Lexicon Pharmaceuticals, Inc. – Pipeline Analysis
Lexicon Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
Lexicon Pharmaceuticals, Inc. - Pipeline Products By Target
Lexicon Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
Lexicon Pharmaceuticals, Inc. – Pipeline Products by Molecule Type
Lexicon Pharmaceuticals, Inc. – Recent Pipeline Updates
Lexicon Pharmaceuticals, Inc. - Dormant Projects
Lexicon Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
LG843
Lexicon Pharmaceuticals, Inc. – Company Statement
Lexicon Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Lexicon Pharmaceuticals, Inc., Deals Volume Summary, 2004 to YTD 2011
Lexicon Pharmaceuticals, Inc., Deals Summary By Region, 2004 to YTD 2011
Lexicon Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011
Lexicon Pharmaceuticals, Inc. Detailed Deal Summary
Equity Offering
Lexicon Pharmaceuticals Completes Public Offering Of $57 Million
Lexicon Pharmaceuticals Completes Private Placement Of $205 Million
Lexicon Completes Private Placement Of $40 Million
Lexicon Completes Issue Of $3.67 million
BioSeek Enters Into Research Agreement With Lexicon Pharmaceuticals
Nuevolution Enters Into Co-Development Agreement With Lexicon Pharmaceuticals
Lexicon Enters Into Co-Development Agreement With Symphony
Lexicon Extends Collaboration With Bristol-Myers
Takeda Enters Into Co-Development Agreement With Lexicon
Lexicon Expands Collaboration With Genentech
Lexicon Enters Into Collaboration Agreement With XOMA
Lexicon Enters Into Agreement With Organon
Lexicon Enters Into Collaboration Agreement With Takeda
XOMA Terminates Co-Development Agreement With Lexicon Pharmaceuticals
Licensing Agreements
Lexicon Pharmaceuticals Enter Into License Agreement With Cellectis
Lexicon Expands Its Licensing Agreement With Stem Cell
Lexicon Enters Into Licensing Agreement With Johnson & Johnson
Lexicon Extends Licensing Agreement With Roche
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Lexicon Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Lexicon Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Lexicon Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Lexicon Pharmaceuticals, Inc. - Phase II, 2011
Lexicon Pharmaceuticals, Inc. - Phase I, 2011
Lexicon Pharmaceuticals, Inc. - Pipeline By Therapeutic Class, 2011
Lexicon Pharmaceuticals, Inc. - Pipeline By Target, 2011
Lexicon Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011
Lexicon Pharmaceuticals, Inc. – Pipeline By Molecule Type, 2011
Lexicon Pharmaceuticals, Inc. – Recent Pipeline Updates, 2011
Lexicon Pharmaceuticals, Inc. - Dormant Developmental Projects, 2010
Lexicon Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2010
Lexicon Pharmaceuticals, Inc., Subsidiaries
Lexicon Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011
Lexicon Pharmaceuticals, Inc., Deals Summary by Region, 2004 to YTD 2011
Lexicon Pharmaceuticals, Inc., Deals Summary, 2004 to YTD 2011

List of Figures
Lexicon Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Lexicon Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Lexicon Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Lexicon Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2011
Lexicon Pharmaceuticals, Inc. - Pipeline By Target, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Idenix Pharmaceuticals, Inc.
• Scientific Games Corporation - Company Analysis
• eBay - Strong Execution
• Abbott Laboratories - IT Sales Opportunities - 2009
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• Ixia - Company Analysis